(Q53669235)

17 May 2018

title

Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis. (English)

1 reference

17 May 2018

0 references

1

1 reference

17 May 2018

Mohsen Khademi

2

1 reference

17 May 2018

author name string

Daniel G Sar

3

1 reference

17 May 2018

Jesper Z Haeggström

4

1 reference

17 May 2018

Jon O Lundberg

5

1 reference

17 May 2018

Fredrik Piehl

6

1 reference

17 May 2018

Tomas Olsson

7

1 reference

17 May 2018

Craig E Wheelock

8

1 reference

17 May 2018

publication date

5 December 2014

1 reference

17 May 2018

Multiple Sclerosis Journal

published in

1 reference

17 May 2018

volume

21

1 reference

17 May 2018

issue

10

1 reference

17 May 2018

page(s)

1271-1279

1 reference

17 May 2018

https://api.crossref.org/works/10.1177%2F1352458514561908

1 reference

Body fluid biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Identification of autoantibodies associated with myelin damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Autoimmune T cell responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Cerebral lipids in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Lipids in cerebrospinal fluid. XII. In multiple sclerosis and retrobulbar neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Chain length-specific properties of ceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

Natalizumab therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561908

21 January 2018

Identifiers

DOI

10.1177/1352458514561908

1 reference

17 May 2018

1 reference

17 May 2018